#CLL

Ventricular Arrhythmias and Sudden Death Events following Acalabrutinib initiation ashpublications.org/blood/article/…

Ahead of #WorldCLL day tomorrow, we're revisiting our blog with Professor Freda Stevenson about how we can improve things for people with the disease. From defining two types of CLL, to thinking about how we might prevent it altogether, read on! #WCLLD22 bloodcancer.org.uk/research/the-r…

#WCLLD22

An enigmatic illness, underdiagnosed, unseen suffering. And the awfully slow recovery process, uncertainty at every step.

How can you Thrive with #CLL? Register for our upcoming webinar on Oct 26 with Seema Ali Bhat of The James #bloodcancer #leusm #CLLsm buff.ly/3SEZ5Et

A caution when you apply ALPINE to all. You may burn the option of Pirtobrutinib. #CLL

At #davawhistler

Contribute to the #CLL literature . Join us to make thus Special Issue shine.

A CSF leak is a life changing experience. It can devastate the lives of those it happens to as well as their circle of family and friends. We work tirelessly to raise awareness within the medical communities and wider public Spinal CSF Leak Foundation Spinal CSF Leak Canada Charitable Organization #LeakWeek2023 #csfleak

Time to demonstrate leadership to everyone most importantly for our patients Today’s junior doctors are tomorrow’s consultant work force Workforce is the most critical resource

My #iwCLL2023 defining moment. With the legends of #CLL

District Champs! Go Celts

Drs. Daniel Addison, MD & Danielle Shafer discuss Harmony in Hematology: CV Risk Mitigation and Monitoring in #CLL Cases #CardioOnc #ACCCardioOnc #leusm

Our ACCC AMCCBS Pre-Conference is happening now! Here is Dr. Seema Bhat, Dr. Joshua Brody, Dr. Naval Daver, and Dr. Brian Hill discussing CLL, DLBCL, and hodgkin lymphoma. View the agenda: bit.ly/3TgUfQc #acccamccbs #hematology

People affected by spinal CSF leak share what they most want doctors to know in this moving compilation originally presented at the Bridging the Gap Conference on November 11, 2023: youtu.be/dDjop7lGWPM #leakweek

Everyone in the medical field should know about #SpinalCSFleak

CONGRESS #EHA2024 | Nitin Jain MD Anderson Cancer Center reports results of the phase 2 trial of pirtobrutinib, venetoclax & obinutuzumab in first-line treatment of pts with CLL. N=40, mFU=11.7 mo, 6 mo uMRD was 64% (PB=79%), 12-mo uMRD was 85% (PB=90%). Safety profile was similar to the

Barbara Eichorst, #CLL overview, #EHA24 time limited treatment, start venetoclax obinotuzumab for all, add BTKi if TP53 mut or del17p an option. Zanubrutinib better than ibrutinib. Non covalent BTKi also inferior in TP53 mut. Komplex Karytope > 3 mutations, more aggressive

Come to The Junto, downtown Columbus and spend the evening with us on Dec 16th..fresh and bubbling from ASH24